Technical analysis of Aytu BioPharma, Inc. (AYTU): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Aytu BioPharma, Inc. is a specialized pharmaceutical firm dedicated to advancing and marketing innovative therapeutic drugs and consumer health products, serving both domestic U.S. and international markets.
Price Performance
| 1 month | -16.95% |
| 3 months | -15.15% |
| Year-to-date | -24.62% |
| 1 year | -15.52% |
| 3 years | +19.51% |
| 5 years | -96.87% |
52-Week Range
| 52-week High | $3.07 |
| 52-week Low | $1.65 |
| Avg Volume (90d) | 33K |
Technical Indicators
| SMA 50 | $2.22 |
| SMA 200 | $2.38 |
| Beta | 0.28 |
| 30-day Volatility (annualised) | 34.4% |
| Price vs SMA 50 | -11.8% |
| Price vs SMA 200 | -17.8% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $2.27 | |
| 2025-11 | $2.19 | -3.5% |
| 2025-12 | $2.60 | +18.7% |
| 2026-01 | $2.60 | +0.0% |
| 2026-02 | $2.57 | -1.2% |
| 2026-03 | $2.73 | +6.2% |
| 2026-04 | $2.58 | -5.5% |
| 2026-05 | $2.29 | -11.2% |
| 2026-06 | $2.15 | -6.1% |
| 2026-07 | $2.23 | +3.7% |
| 2026-08 | $2.29 | +2.7% |
| 2026-09 | $1.96 | -14.4% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | | |
| 2026-09-14 | | $563M |
| 2026-09-14 | | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $0.20 | $23M |
| 2026-09-14 | | |
Price
| Price | $1.97 |
| Market Cap | $21M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.58 |
| EV / EBITDA | -0.73 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.65 |
| Current Ratio | 1.12 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -3.20 |